Clinical Trial Update: taVNS for Anxiety in ASD [NA]

View source ↗

Summary

A clinical trial evaluating transcutaneous auricular vagus nerve stimulation (taVNS) for anxiety in autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Autism Spectrum Disorder

Drugs mentioned

• taVNS device (transcutaneous auricular vagus nerve stimulator)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Autism Spectrum Disorder, Anxiety | NA | Status: COMPLETED